The latest announcement is out from Sharps Technology, Inc. ( (STSS) ).
On March 20, 2025, Sharps Technology, Inc. issued a press release urging shareholders to vote in favor of a proposed reverse stock split at the upcoming shareholder meeting on March 28, 2025. The reverse stock split is crucial for maintaining the company’s Nasdaq listing, as it ensures compliance with Nasdaq’s minimum bid price requirement. Failure to approve the proposal could result in the company’s stock being delisted to the OTC Markets, which would negatively impact liquidity and shareholder value.
More about Sharps Technology, Inc.
Sharps Technology, Inc. is an innovative medical device and pharmaceutical packaging company that specializes in patented, smart-safety syringe products. The company focuses on providing ultra-low waste capabilities with both passive and active safety features, and it supports the prefillable syringe market segment with specialized copolymer technology. Sharps Technology operates a manufacturing facility in Hungary.
YTD Price Performance: -84.93%
Average Trading Volume: 16,027,206
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.83M
Find detailed analytics on STSS stock on TipRanks’ Stock Analysis page.